EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Case report; successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura



Case report; successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura



Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(1): 147-149




(PDF emailed within 1 workday: $29.90)

Accession: 051964874

Download citation: RISBibTeXText

PMID: 23777126



Related references

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. American Journal of Hematology 78(1): 49-54, 2004

Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports. Medicine and Health, Rhode Island 91(7): 226-228, 2008

Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange. Japanese Journal of Clinical Hematology 51(2): 127-131, 2010

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. American Journal of Hematology 78(1): 49-54, 2004

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review. Pediatric Critical Care Medicine 12(2): E90-E93, 2011

Successful Treatment of Severe and Refractory Thrombotic Thrombocytopenic Purpura with Early Rituximab Administration. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 106(1): 99-106, 2017

Successful rituximab treatment in an elderly patient with recurrent thrombotic thrombocytopenic purpura. Japanese Journal of Clinical Hematology 57(7): 869-872, 2016

Refractory thrombotic thrombocytopenic purpura associated with primary Sjogren syndrome treated with rituximab: a case report. American Journal of Therapeutics 21(2): E56-E60, 2014

Successful treatment with rituximab of a patient with coincident acquired hemophilia A and thrombotic thrombocytopenic purpura. Japanese Journal of Clinical Hematology 56(11): 2318-2323, 2016

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Swiss Medical Weekly 137(37-38): 518-524, 2007

Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome. International Journal of Hematology 90(2): 174-176, 2009

Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases. Japanese Journal of Clinical Hematology 54(2): 205-209, 2013

Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports. Medicine and Health, Rhode Island 91(7): 226-228, 2008

A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab. South African Medical Journal 106(7): 689-691, 2016

Rituximab for the Treatment of Relapsing/Refractory Thrombotic Thrombocytopenic Purpura. Blood 100(11): Abstract No 2703, November 16, 2002